Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial

Ruben Y.G. Tijssen1, MD; Robin P. Kraak1, MD; Joelle Elias1, MD; Ivo M. van Dongen1, MD; Deborah N. Kalkman1, MD; Martina Nassif1, MD; Yohei Sotomi1, MD; Taku Asano1, MD; Yuki Katagiri1, MD; Carlos Collet1, MD; Jan J. Piek1, MD, PhD; Jose P. Henriques1, MD, PhD; Robbert J. de Winter1, MD, PhD; Jan G.P. Tijssen1, PhD; Yoshinobu Onuma2,3, MD, PhD; Patrick W. Serruys4, MD, PhD; Joanna J. Wykrzykowska1*, MD, PhD